arsphenamine
Quick Summary
Arsphenamine, also known as Salvarsan, is a light-yellow, toxic powder that was historically used to treat syphilis and yaws. Developed in 1910 by Paul Ehrlich, it was the first synthetic drug specifically designed to combat a particular infectious organism, marking the beginning of the chemotherapy era. This arsenic compound was effective against the bacterium responsible for syphilis and remained a primary treatment until the widespread adoption of penicillin in the 1940s. Ehrlich's methodical approach of synthesizing and screening numerous compounds to find an effective treatment became a foundational method for drug development in the pharmaceutical industry.1234
Ask Britannica AI about this topic
Britannica doesn't have a full article on this topic, so we've curated a list of our relevant coverage.
chemotherapy…of the organic arsenical drug Salvarsan, which proved to be effective in the treatment of syphilis. The discovery of other chemotherapeutic agents followed, including mepacrine, proguanil, and chloroquine.
Read More…of the organic arsenical drug Salvarsan, which proved to be effective in the treatment of syphilis. The discovery of other chemotherapeutic agents followed, including mepacrine, proguanil, and chloroquine.
Read More
Paul EhrlichSyphilis studiesHis preparation 606, later called Salvarsan, was extraordinarily effective and harmless despite its large arsenic content. The first tests, announced in the spring of 1910, proved to be surprisingly successful in the treatment of a whole spectrum of diseases; in the case of yaws, a tropical disease akin to syphilis,…
Read MoreHis preparation 606, later called Salvarsan, was extraordinarily effective and harmless despite its large arsenic content. The first tests, announced in the spring of 1910, proved to be surprisingly successful in the treatment of a whole spectrum of diseases; in the case of yaws, a tropical disease akin to syphilis,…
Read More
syphilisSyphilis through history…arsenic compound commonly known as Salvarsan or 606—was developed in 1909 by the German bacteriologist Paul Ehrlich. Much was learned about the course of the disease from the infamous Tuskegee syphilis study (1932–72). The use of antibiotics developed in 1943 after the discovery by the American physician John Friend Mahoney…
Read More…arsenic compound commonly known as Salvarsan or 606—was developed in 1909 by the German bacteriologist Paul Ehrlich. Much was learned about the course of the disease from the infamous Tuskegee syphilis study (1932–72). The use of antibiotics developed in 1943 after the discovery by the American physician John Friend Mahoney…
Read More
pharmaceutical industryEarly efforts in the development of anti-infective drugsThe first of these was arsphenamine, which was developed in 1910 by the German medical scientist Paul Ehrlich for the treatment of syphilis. Arsphenamine was the 606th chemical studied by Ehrlich in his quest for an antisyphilitic drug. Its efficacy was first demonstrated in mice with syphilis and then in…
Read MoreThe first of these was arsphenamine, which was developed in 1910 by the German medical scientist Paul Ehrlich for the treatment of syphilis. Arsphenamine was the 606th chemical studied by Ehrlich in his quest for an antisyphilitic drug. Its efficacy was first demonstrated in mice with syphilis and then in…
Read More
